About this trial
Ankylosing spondylitis (AS) is a chronic rheumatic disease with unique clinical, pathophysiological, radiographic and genetic features, the etiology of which is not known for sure, and is characterized by sacroiliac and spinal joint involvement. It is reported that this disease affects one in every 200 people, is usually diagnosed years after the onset of symptoms, and negatively affects quality of life. The prevalence of AS is between 0.2% and 1.1%, and symptoms begin before the age of 30 in approximately 80% of cases. The main complaints of patients diagnosed with AS include pain, joint stiffness, fatigue, and functional limitations of various degrees. Functional limitations resulting from inflammation and/or bone formations affect daily life activities, especially the person's ability to participate in leisure and domestic activities, and work productivity, and can limit social roles in the family and society. It is reported in the literature that regular PGE reduces pain and fatigue, facilitates the transition to sleep, and improves quality of life. In this context, this study aimed to evaluate the effect of PGE in reducing pain and fatigue frequently experienced by AS patients and to contribute to symptom management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having AS diagnosis
Volunteering to participate in the study
Being over 18 years of age
Having internet access
Disqualifiers
Having an orthopedic disability that prevents PGE
Being pregnant
Scoring 24 or less from the Mini Mental Test for individuals over 65 years of age
Wanting to leave the study
Trial design
Parallel
Treatments tested in this trial
Progressive Relaxation Exercises
Other interventionProgressive Relaxation Exercises are defined as "a method that provides relaxation throughout the body by voluntary, regular relaxation of large muscle groups in the human body." The main purpose of relaxation exercises is for individuals to feel the difference between tension and relaxation in the muscles and to learn to relax on their own in cases of tension.
Treatment groups
Trial outcomes
Primary outcomes
PGE intervention and control
When comparing the results of the PGE(PRE) Intervention and Control Group; A comparison will be made as to whether the applied Progressive Relaxation Exercises have an effect on pain and fatigue or not. Data will be evaluated using the Statistical Package for Social Sciences-SPSS 25.0 package program, and frequency, percentage, mean and standard deviation will be used as descriptive statistics, and Shapiro Wilk test will be used to check the normal distribution of continuous variables. Student t, Chi-square, Mann-Whitney U and Kruskal Wallis, Anova tests will be applied under appropriate conditions to examine the differences between categorical variables. The statistical significance level will be accepted as p\<0.05.
VAS
Visual Analog Scale (VAS): This scale is a measurement tool with 10 on one end and 0 on the other. The patient is asked to mark a point that corresponds to the intensity of pain they feel. They are told to accept the time they do not feel any pain as "0" and the time they feel the most severe pain as "10", and the numerical value found shows the patient's intensity of pain. The pain levels of the group that will do progressive relaxation exercises will be assessed with VAS after each PGE. In addition, the pain levels of the patients in the control group will be assessed with VAS simultaneously with the group that receives PGE.
PİPER
Fatigue Piper Fatigue Scale (PFS): It is a tool consisting of 22 items and four sub-dimensions that subjectively measure one-month fatigue. Each item is rated from weak (1 point) to strong (10 points). The total score is found by summing up the answers to all items and dividing by the number of items. The maximum score that can be obtained from the scale is 10, and the minimum score is 0. An increase in the score means that the fatigue felt by the person is high. The fatigue level of the patients in the group that will do progressive relaxation exercises and the control group will be evaluated with the PFS every four weeks, at the beginning, the 4th week and the 8th week.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: